D. Menchaca

Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.

E. Shpall, L. Chap, J. Glaspy, 1997, Blood.

Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation

B. Overmoyer, L. Chap, J. Glaspy, 2000, Bone Marrow Transplantation.

Clinical applications of filgrastim and stem cell factor in vivo and in vitro.

E. Shpall, J. Glaspy, G. Morstyn, 1994, Journal of hematotherapy.

Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo

G. Demetri, S. Galli, A. Dvorak, 1996, The Journal of experimental medicine.

Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer.

R. Figlin, J. Crawford, L. Harker, 1997, The New England journal of medicine.